Priyanshu Rathod
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Priyanshu Rathod has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chetankumar M. Patel
Mechanical Department School of Engineering RK University Rajkot Gujarat India
1 shared publication - Khushboo Parmar
School of Physiotherapy RK University Rajkot Gujarat India
1 shared publication - Kiran Dudhat
School of Pharmacy, RK University, Rajkot, India
1 shared publication - Krishi Kamdar
School of Physiotherapy, RK University, Bhavnagar Highway, Kasturbadham, Rajkot, Gujarat, 360020, India
1 shared publication - Parthkumar Devmurari
RK University, School of Physiotherapy, Rajkot, India
1 shared publication - Pravin Tirgar
Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
1 shared publication
Latest Publications
- Open Access
- 1 March 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (1) , 215-226
Design and testing of breathing retraining device a multiphasic exploratory study in healthy subjects
Introduction and aim. Traditional spirometers are limited by bulkiness and lack of biofeedback, which can hinder their effec tiveness in pulmonary rehabilitation. This study aimed to evaluate the accuracy of an innovative breathing retraining device in measuring inhaled volume and assess user satisfaction compared to standard spirometers. Material and methods. A multiphasic exploratory study was conducted with 102 healthy adults (aged 18–60 years). The study included three phases: need analysis through focus group discussions, prototype development using polycarbonate materials and 3D printing, and effectiveness testing. Inhalation exercises were performed with both the new device and a standard spi rometer. Primary outcomes were inhaled volume and marker displacement, with user satisfaction assessed via the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire. Results. The new device showed a strong correlation between inhaled volume and marker displacement (r=0.842, p<0.001). The mean inhaled volume was 2.07±0.61 liters, with a mean marker displacement of 5.19±0.59 cm. The mean QUEST 2.0 satis faction score was 3.54, indicating high user satisfaction. Conclusion. The redesigned breathing retraining device not only addresses critical gaps in existing technologies but also offers a practical, user-friendly solution for pulmonary rehabilitation. By combining accuracy, real-time feedback, and portability, this innovation has the potential to redefine respiratory therapy standards in both clinical and home-based settings, paving the way for broader applications and improved patient outcomes.
- 1 March 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (1) , 215-226
Open AccessDesign and testing of breathing retraining device a multiphasic exploratory study in healthy subjects
Introduction and aim. Traditional spirometers are limited by bulkiness and lack of biofeedback, which can hinder their effec tiveness in pulmonary rehabilitation. This study aimed to evaluate the accuracy of an innovative breathing retraining device in measuring inhaled volume and assess user satisfaction compared to standard spirometers. Material and methods. A multiphasic exploratory study was conducted with 102 healthy adults (aged 18–60 years). The study included three phases: need analysis through focus group discussions, prototype development using polycarbonate materials and 3D printing, and effectiveness testing. Inhalation exercises were performed with both the new device and a standard spi rometer. Primary outcomes were inhaled volume and marker displacement, with user satisfaction assessed via the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire. Results. The new device showed a strong correlation between inhaled volume and marker displacement (r=0.842, p<0.001). The mean inhaled volume was 2.07±0.61 liters, with a mean marker displacement of 5.19±0.59 cm. The mean QUEST 2.0 satis faction score was 3.54, indicating high user satisfaction. Conclusion. The redesigned breathing retraining device not only addresses critical gaps in existing technologies but also offers a practical, user-friendly solution for pulmonary rehabilitation. By combining accuracy, real-time feedback, and portability, this innovation has the potential to redefine respiratory therapy standards in both clinical and home-based settings, paving the way for broader applications and improved patient outcomes.
- 19 February 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 20 (4) , 1-26
Gold Nanoparticles in the Treatment of Soft Tissue Injury: A SystematicReview
Background: Nanotechnology has gained significant attention in recent years as a promising approach for addressing a variety of medical challenges, including soft tissue injuries. Among the different nanomaterials, gold nanoparticles (GNPs) stand out due to their unique and versatile physicochemical properties. These properties include their small size, customizable shape, and adaptable surface chemistry, which allow GNPs to be tailored for specific therapeutic purposes. The growing interest in GNPs stems from their potential to enhance drug delivery, improve healing processes, and reduce side effects in the treatment of soft tissue injuries. This review provides a comprehensive examination of the efficacy of GNPs in the context of soft tissue injury treatment, exploring both their therapeutic potential and associated risks. Objectives: The primary objective of this review is to evaluate the effectiveness of gold nanoparticles in treating soft tissue injuries. This is achieved through the following specific goals: Formulation of GNPs Gel: Investigating the methods used to formulate GNPs into a gel form suitable for application in soft tissue injuries. This includes an analysis of different formulation techniques and the materials used to stabilize and deliver the nanoparticles. Skin Penetration Methods: It explores various methods by which GNP gel can penetrate the skin to reach the underlying soft tissues. This involves a review of topical application techniques, including both conventional and advanced methods, to determine their effectiveness in delivering GNPs to the site of injury. Therapeutic Benefits and Toxicity: These include assessing the therapeutic benefits of GNPs when applied to soft tissue injuries, with a focus on the observed outcomes in both animal models and human studies. Additionally, the review examines the potential toxicity of GNPs, particularly when administered through different routes, to ensure that their use is both safe and effective. Methods: A systematic review of the literature was conducted to gather relevant studies on the use of GNPs for treating soft tissue injuries. Articles were sourced from well-known scientific databases, including PubMed, Medline, and Wiley, covering publications from 2008 to 2020. A total of 119 articles were initially identified for review. After removing 24 duplicates and excluding 90 articles that did not meet the eligibility criteria, five articles were selected for in-depth full-text analysis and synthesis. These selected studies provided valuable insights into the formulation, application, and safety of GNPs in treating soft tissue injuries. Results: The findings from the reviewed studies suggest that GNPs show considerable promise in treating soft tissue injuries, particularly in animal models. One of the effective methods for formulating GNPs into a gel involved the Turkevich method, which utilizes base materials such as Carbol 934, glycerin, and PEG 400. This formulation method has demonstrated several advantages, including ease of preparation and stability of the resulting gel. In terms of application, topical administration of GNP gel has proven to be an effective method for achieving skin penetration and delivering therapeutic benefits. Techniques such as gentle rubbing of the skin and the use of phonophoresis have been highlighted as particularly effective. However, it is important to note that while topical application appears safe, other administration routes, such as oral or intravenous delivery of GNPs, particularly those with small sizes and spherical shapes, have been associated with toxicity in various organs and can lead to cellular DNA damage. Conclusion: The review concludes that topical administration of GNP gel holds significant potential for controlled and targeted drug delivery in the treatment of soft tissue injuries. This method allows for localized treatment, reducing the risk of systemic side effects and improving therapeutic outcomes. However, the review also emphasizes the need for careful consideration of potential cellular-level toxicity, particularly when GNPs are used in humans. Further research is required to fully understand the long-term safety and efficacy of GNPs, ensuring that they can be safely integrated into clinical practice for the treatment of soft tissue injuries.
- 19 February 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 20 (4) , 1-26
Gold Nanoparticles in the Treatment of Soft Tissue Injury: A SystematicReview
Background: Nanotechnology has gained significant attention in recent years as a promising approach for addressing a variety of medical challenges, including soft tissue injuries. Among the different nanomaterials, gold nanoparticles (GNPs) stand out due to their unique and versatile physicochemical properties. These properties include their small size, customizable shape, and adaptable surface chemistry, which allow GNPs to be tailored for specific therapeutic purposes. The growing interest in GNPs stems from their potential to enhance drug delivery, improve healing processes, and reduce side effects in the treatment of soft tissue injuries. This review provides a comprehensive examination of the efficacy of GNPs in the context of soft tissue injury treatment, exploring both their therapeutic potential and associated risks. Objectives: The primary objective of this review is to evaluate the effectiveness of gold nanoparticles in treating soft tissue injuries. This is achieved through the following specific goals: Formulation of GNPs Gel: Investigating the methods used to formulate GNPs into a gel form suitable for application in soft tissue injuries. This includes an analysis of different formulation techniques and the materials used to stabilize and deliver the nanoparticles. Skin Penetration Methods: It explores various methods by which GNP gel can penetrate the skin to reach the underlying soft tissues. This involves a review of topical application techniques, including both conventional and advanced methods, to determine their effectiveness in delivering GNPs to the site of injury. Therapeutic Benefits and Toxicity: These include assessing the therapeutic benefits of GNPs when applied to soft tissue injuries, with a focus on the observed outcomes in both animal models and human studies. Additionally, the review examines the potential toxicity of GNPs, particularly when administered through different routes, to ensure that their use is both safe and effective. Methods: A systematic review of the literature was conducted to gather relevant studies on the use of GNPs for treating soft tissue injuries. Articles were sourced from well-known scientific databases, including PubMed, Medline, and Wiley, covering publications from 2008 to 2020. A total of 119 articles were initially identified for review. After removing 24 duplicates and excluding 90 articles that did not meet the eligibility criteria, five articles were selected for in-depth full-text analysis and synthesis. These selected studies provided valuable insights into the formulation, application, and safety of GNPs in treating soft tissue injuries. Results: The findings from the reviewed studies suggest that GNPs show considerable promise in treating soft tissue injuries, particularly in animal models. One of the effective methods for formulating GNPs into a gel involved the Turkevich method, which utilizes base materials such as Carbol 934, glycerin, and PEG 400. This formulation method has demonstrated several advantages, including ease of preparation and stability of the resulting gel. In terms of application, topical administration of GNP gel has proven to be an effective method for achieving skin penetration and delivering therapeutic benefits. Techniques such as gentle rubbing of the skin and the use of phonophoresis have been highlighted as particularly effective. However, it is important to note that while topical application appears safe, other administration routes, such as oral or intravenous delivery of GNPs, particularly those with small sizes and spherical shapes, have been associated with toxicity in various organs and can lead to cellular DNA damage. Conclusion: The review concludes that topical administration of GNP gel holds significant potential for controlled and targeted drug delivery in the treatment of soft tissue injuries. This method allows for localized treatment, reducing the risk of systemic side effects and improving therapeutic outcomes. However, the review also emphasizes the need for careful consideration of potential cellular-level toxicity, particularly when GNPs are used in humans. Further research is required to fully understand the long-term safety and efficacy of GNPs, ensuring that they can be safely integrated into clinical practice for the treatment of soft tissue injuries.